{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:06:13Z","timestamp":1783944373920,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T00:00:00Z","timestamp":1728000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hainan Provincial Natural Science Foundation of China","award":["No. 820RC769 and No.822RC839"],"award-info":[{"award-number":["No. 820RC769 and No.822RC839"]}]},{"name":"Hainan Provincial Natural Science Foundation of China","award":["No. 820RC769 and No.822RC839"],"award-info":[{"award-number":["No. 820RC769 and No.822RC839"]}]},{"name":"Hainan Provincial Natural Science Foundation of China","award":["No. 820RC769 and No.822RC839"],"award-info":[{"award-number":["No. 820RC769 and No.822RC839"]}]},{"name":"Hainan Provincial Natural Science Foundation of China","award":["No. 820RC769 and No.822RC839"],"award-info":[{"award-number":["No. 820RC769 and No.822RC839"]}]},{"name":"Hainan Provincial Natural Science Foundation of China","award":["No. 820RC769 and No.822RC839"],"award-info":[{"award-number":["No. 820RC769 and No.822RC839"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-024-01573-6","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T05:02:04Z","timestamp":1728018124000},"page":"1631-1643","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["COL6A1 Inhibits the Malignant Development of Bladder Cancer by Regulating FBN1"],"prefix":"10.1007","volume":"83","author":[{"given":"Tineng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"issue":"6","key":"1573_CR1","doi-asserted-by":"publisher","first-page":"783","DOI":"10.6004\/jnccn.2020.7585","volume":"18","author":"ER Kessler","year":"2020","unstructured":"Kessler, E. R., Kukreja, J. B., Geiger, C. L., & Fischer, S. M. (2020). Treating elderly patients with muscle-invasive bladder cancer. Journal of the National Comprehensive Cancer Network, 18(6), 783\u2013790. https:\/\/doi.org\/10.6004\/jnccn.2020.7585.","journal-title":"Journal of the National Comprehensive Cancer Network"},{"issue":"5","key":"1573_CR2","doi-asserted-by":"publisher","first-page":"Cd003781","DOI":"10.1002\/14651858.CD003781.pub3","volume":"5","author":"A Stoniute","year":"2023","unstructured":"Stoniute, A., Madhuvrata, P., Still, M., Barron-Millar, E., Nabi, G., & Omar, M. I. (2023). Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults. Cochrane Database of Systematic Reviews, 5(5), Cd003781. https:\/\/doi.org\/10.1002\/14651858.CD003781.pub3.","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"1573_CR3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11427-020-1768-y","volume":"64","author":"Z Wu","year":"2021","unstructured":"Wu, Z., Liu, J., Dai, R., & Wu, S. (2021). Current status and future perspectives of immunotherapy in bladder cancer treatment. Science China Life Sciences, 64(4), 512\u2013533. https:\/\/doi.org\/10.1007\/s11427-020-1768-y.","journal-title":"Science China Life Sciences"},{"key":"1573_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ijsu.2020.01.128","volume":"75","author":"A Mainwaring","year":"2020","unstructured":"Mainwaring, A., Bullock, N., Ellul, T., Hughes, O., & Featherstone, J. (2020). The top 100 most cited manuscripts in bladder cancer: A bibliometric analysis (review article). International Journal of Surgery, 75, 130\u2013138. https:\/\/doi.org\/10.1016\/j.ijsu.2020.01.128.","journal-title":"International Journal of Surgery"},{"key":"1573_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106475","volume":"185","author":"M Hashemi","year":"2022","unstructured":"Hashemi, M., Arani, H. Z., Orouei, S., Rostamnejad, E., Ghorbani, A., Khaledabadi, M., Kakavand, A., Tavakolpournegari, A., Saebfar, H., Heidari, H., Salimimoghadam, S., Taheriazam, A., Entezari, M., & Khan, H. (2022). Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions. Pharmacological Research, 185, 106475. https:\/\/doi.org\/10.1016\/j.phrs.2022.106475.","journal-title":"Pharmacological Research"},{"issue":"10","key":"1573_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41585-019-0226-y","volume":"16","author":"AK Schneider","year":"2019","unstructured":"Schneider, A. K., Chevalier, M. F., & Derr\u00e9, L. (2019). The multifaceted immune regulation of bladder cancer. Nature Reviews Urology, 16(10), 613\u2013630. https:\/\/doi.org\/10.1038\/s41585-019-0226-y.","journal-title":"Nature Reviews Urology"},{"issue":"2","key":"1573_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.chest.2018.10.041","volume":"155","author":"DE Schraufnagel","year":"2019","unstructured":"Schraufnagel, D. E., Balmes, J. R., Cowl, C. T., De Matteis, S., Jung, S. H., Mortimer, K., Perez-Padilla, R., Rice, M. B., Riojas-Rodriguez, H., Sood, A., Thurston, G. D., To, T., Vanker, A., & Wuebbles, D. J. (2019). Air pollution and noncommunicable diseases: A review by the Forum of International Respiratory Societies\u2019 Environmental Committee, Part 2: Air pollution and organ systems. Chest, 155(2), 417\u2013426. https:\/\/doi.org\/10.1016\/j.chest.2018.10.041.","journal-title":"Chest"},{"key":"1573_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.watres.2019.07.014","volume":"162","author":"M Diana","year":"2019","unstructured":"Diana, M., Felipe-Sotelo, M., & Bond, T. (2019). Disinfection byproducts potentially responsible for the association between chlorinated drinking water and bladder cancer: A review. Water Research, 162, 492\u2013504. https:\/\/doi.org\/10.1016\/j.watres.2019.07.014.","journal-title":"Water Research"},{"issue":"Pt 3","key":"1573_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.semcancer.2021.12.010","volume":"86","author":"A Yacouba","year":"2022","unstructured":"Yacouba, A., Tidjani Alou, M., Lagier, J. C., Dubourg, G., & Raoult, D. (2022). Urinary microbiota and bladder cancer: A systematic review and a focus on uropathogens. Seminars in Cancer Biology, 86(Pt 3), 875\u2013884. https:\/\/doi.org\/10.1016\/j.semcancer.2021.12.010.","journal-title":"Seminars in Cancer Biology"},{"issue":"4","key":"1573_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/pharmaceutics15041117","volume":"15","author":"Y Kang","year":"2023","unstructured":"Kang, Y., Park, C., Lee, H., Kang, S., Cheon, C., & Kim, B. (2023). Natural products as new approaches for treating bladder cancer: From traditional medicine to novel drug discovery. Pharmaceutics, 15(4), 1117. https:\/\/doi.org\/10.3390\/pharmaceutics15041117.","journal-title":"Pharmaceutics"},{"issue":"4","key":"1573_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1158\/1078-0432.Ccr-15-1135","volume":"22","author":"A Ghasemzadeh","year":"2016","unstructured":"Ghasemzadeh, A., Bivalacqua, T. J., Hahn, N. M., & Drake, C. G. (2016). New strategies in bladder cancer: A second coming for immunotherapy. Clinical Cancer Research, 22(4), 793\u2013801. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-1135.","journal-title":"Clinical Cancer Research"},{"issue":"8","key":"1573_CR12","doi-asserted-by":"publisher","first-page":"7585","DOI":"10.3390\/ijms24087585","volume":"24","author":"A Zo\u0144","year":"2023","unstructured":"Zo\u0144, A., & Bednarek, I. (2023). Cisplatin in ovarian cancer treatment-known limitations in therapy force new solutions. International Journal of Molecular Sciences, 24(8), 7585. https:\/\/doi.org\/10.3390\/ijms24087585.","journal-title":"International Journal of Molecular Sciences"},{"key":"1573_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102000","volume":"86","author":"R Morales-Barrera","year":"2020","unstructured":"Morales-Barrera, R., Su\u00e1rez, C., Gonz\u00e1lez, M., Valverde, C., Serra, E., Mateo, J., Raventos, C., Maldonado, X., Morote, J., & Carles, J. (2020). The future of bladder cancer therapy: Optimizing the inhibition of the fibroblast growth factor receptor. Cancer Treatment Reviews, 86, 102000. https:\/\/doi.org\/10.1016\/j.ctrv.2020.102000.","journal-title":"Cancer Treatment Reviews"},{"key":"1573_CR14","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jconrel.2023.01.001","volume":"354","author":"P Zhang","year":"2023","unstructured":"Zhang, P., Wu, G., Zhang, D., & Lai, W. F. (2023). Mechanisms and strategies to enhance penetration during intravesical drug therapy for bladder cancer. Journal of Controlled Release, 354, 69\u201379. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.001.","journal-title":"Journal of Controlled Release"},{"issue":"6","key":"1573_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3109\/03008207.2013.822865","volume":"54","author":"J Fitzgerald","year":"2013","unstructured":"Fitzgerald, J., Holden, P., & Hansen, U. (2013). The expanded collagen VI family: new chains and new questions. Connective Tissue Research, 54(6), 345\u2013350. https:\/\/doi.org\/10.3109\/03008207.2013.822865.","journal-title":"Connective Tissue Research"},{"issue":"4","key":"1573_CR16","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1007\/s13277-013-1511-7","volume":"35","author":"M Fang","year":"2014","unstructured":"Fang, M., Yuan, J., Peng, C., & Li, Y. (2014). Collagen as a double-edged sword in tumor progression. Tumor Biology, 35(4), 2871\u20132882. https:\/\/doi.org\/10.1007\/s13277-013-1511-7.","journal-title":"Tumor Biology"},{"key":"1573_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/606458","volume":"2014","author":"E Karousou","year":"2014","unstructured":"Karousou, E., D\u2019Angelo, M. L., Kouvidi, K., Vigetti, D., Viola, M., Nikitovic, D., De Luca, G., & Passi, A. (2014). Collagen VI and hyaluronan: The common role in breast cancer. BioMed Research International, 2014, 606458. https:\/\/doi.org\/10.1155\/2014\/606458.","journal-title":"BioMed Research International"},{"issue":"7","key":"1573_CR18","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.molmed.2013.04.001","volume":"19","author":"P Chen","year":"2013","unstructured":"Chen, P., Cescon, M., & Bonaldo, P. (2013). Collagen VI in cancer and its biological mechanisms. Trends in Molecular Medicine, 19(7), 410\u2013417. https:\/\/doi.org\/10.1016\/j.molmed.2013.04.001.","journal-title":"Trends in Molecular Medicine"},{"key":"1573_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.564733","volume":"10","author":"PP Wang","year":"2020","unstructured":"Wang, P. P., Ding, S. Y., Sun, Y. Y., Li, Y. H., & Fu, W. N. (2020). MYCT1 inhibits the adhesion and migration of laryngeal cancer cells potentially through repressing collagen VI. Frontiers in Oncology, 10, 564733. https:\/\/doi.org\/10.3389\/fonc.2020.564733.","journal-title":"Frontiers in Oncology"},{"issue":"4","key":"1573_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3892\/etm.2023.11875","volume":"25","author":"X Tian","year":"2023","unstructured":"Tian, X., Sun, J., Li, C., & Zhang, K. (2023). COL4A1 promotes the proliferation and migration of oral squamous cell carcinoma cells by binding to NID1. Experimental and Therapeutic Medicine, 25(4), 176 https:\/\/doi.org\/10.3892\/etm.2023.11875.","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"1","key":"1573_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22953-z","volume":"12","author":"T Budden","year":"2021","unstructured":"Budden, T., Gaudy-Marqueste, C., Porter, A., Kay, E., Gurung, S., Earnshaw, C. H., Roeck, K., Craig, S., Traves, V., Krutmann, J., Muller, P., Motta, L., Zanivan, S., Malliri, A., Furney, S. J., Nagore, E., & Vir\u00f3s, A. (2021). Ultraviolet light-induced collagen degradation inhibits melanoma invasion. Nature Communications, 12(1), 2742 https:\/\/doi.org\/10.1038\/s41467-021-22953-z.","journal-title":"Nature Communications"},{"key":"1573_CR22","doi-asserted-by":"publisher","unstructured":"De Martino, D., & Bravo-Cordero, J. J. (2023) Collagens in cancer: structural regulators and guardians of cancer progression. Cancer Research. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-2034","DOI":"10.1158\/0008-5472.Can-22-2034"},{"key":"1573_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102530","volume":"115","author":"CM Ascione","year":"2023","unstructured":"Ascione, C. M., Napolitano, F., Esposito, D., Servetto, A., Belli, S., Santaniello, A., Scagliarini, S., Crocetto, F., Bianco, R., & Formisano, L. (2023). Role of FGFR3 in bladder cancer: Treatment landscape and future challenges. Cancer Treatment Reviews, 115, 102530. https:\/\/doi.org\/10.1016\/j.ctrv.2023.102530.","journal-title":"Cancer Treatment Reviews"},{"issue":"1","key":"1573_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/btm2.10353","volume":"8","author":"M Ashrafizadeh","year":"2023","unstructured":"Ashrafizadeh, M., Zarrabi, A., Karimi-Maleh, H., Taheriazam, A., Mirzaei, S., Hashemi, M., Hushmandi, K., Makvandi, P., Nazarzadeh Zare, E., Sharifi, E., Goel, A., Wang, L., Ren, J., Nuri Ertas, Y., Kumar, A. P., Wang, Y., Rabiee, N., Sethi, G., & Ma, Z. (2023). (Nano)platforms in bladder cancer therapy: Challenges and opportunities. Bioengineering and Translational Medicine, 8(1), e10353. https:\/\/doi.org\/10.1002\/btm2.10353.","journal-title":"Bioengineering and Translational Medicine"},{"issue":"9","key":"1573_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/jmg.2002.002311","volume":"42","author":"AK Lampe","year":"2005","unstructured":"Lampe, A. K., & Bushby, K. M. (2005). Collagen VI related muscle disorders. Journal of Medical Genetics, 42(9), 673\u2013685. https:\/\/doi.org\/10.1136\/jmg.2002.002311.","journal-title":"Journal of Medical Genetics"},{"key":"1573_CR26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.matbio.2017.12.008","volume":"71-72","author":"SR Lamand\u00e9","year":"2018","unstructured":"Lamand\u00e9, S. R., & Bateman, J. F. (2018). Collagen VI disorders: Insights on form and function in the extracellular matrix and beyond. Matrix Biology, 71-72, 348\u2013367. https:\/\/doi.org\/10.1016\/j.matbio.2017.12.008.","journal-title":"Matrix Biology"},{"issue":"6","key":"1573_CR27","doi-asserted-by":"publisher","first-page":"5095","DOI":"10.3390\/ijms24065095","volume":"24","author":"A Di Martino","year":"2023","unstructured":"Di Martino, A., Cescon, M., D\u2019Agostino, C., Schilardi, F., Sabatelli, P., Merlini, L., & Faldini, C. (2023). Collagen VI in the musculoskeletal system. International Journal of Molecular Sciences, 24(6), 5095. https:\/\/doi.org\/10.3390\/ijms24065095.","journal-title":"International Journal of Molecular Sciences"},{"issue":"20","key":"1573_CR28","doi-asserted-by":"publisher","first-page":"12415","DOI":"10.3390\/ijms232012415","volume":"23","author":"L Necula","year":"2022","unstructured":"Necula, L., Matei, L., Dragu, D., Pitica, I., Neagu, A., Bleotu, C., Diaconu, C. C., & Chivu-Economescu, M. (2022). Collagen family as promising biomarkers and therapeutic targets in cancer. International Journal of Molecular Sciences, 23(20), 12415. https:\/\/doi.org\/10.3390\/ijms232012415.","journal-title":"International Journal of Molecular Sciences"},{"issue":"14","key":"1573_CR29","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.3390\/cancers14143358","volume":"14","author":"M Sarafidis","year":"2022","unstructured":"Sarafidis, M., Lambrou, G. I., Zoumpourlis, V., & Koutsouris, D. (2022). An integrated bioinformatics analysis towards the identification of diagnostic, prognostic, and predictive key biomarkers for urinary bladder cancer. Cancers, 14(14), 3358. https:\/\/doi.org\/10.3390\/cancers14143358.","journal-title":"Cancers"},{"key":"1573_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.790096","volume":"12","author":"MS Huang","year":"2022","unstructured":"Huang, M. S., Fu, L. H., Yan, H. C., Cheng, L. Y., Ru, H. M., Mo, S., Wei, C. Y., Li, D. M., Mo, X. W., Tang, W. Z., & Yan, L. H. (2022). Proteomics and liquid biopsy characterization of human EMT-related metastasis in colorectal cancer. Frontiers in Oncology, 12, 790096. https:\/\/doi.org\/10.3389\/fonc.2022.790096.","journal-title":"Frontiers in Oncology"},{"issue":"5","key":"1573_CR31","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1089\/gtmb.2020.0279","volume":"25","author":"H Lin","year":"2021","unstructured":"Lin, H., Yang, Y., Hou, C., Zheng, J., Lv, G., Mao, R., Xu, P., Chen, S., Zhou, Y., Wang, P., & Zhou, D. (2021). Identification of COL6A1 as the key gene associated with antivascular endothelial growth factor therapy in glioblastoma multiforme. Genetic Testing and Molecular Biomarkers, 25(5), 334\u2013345. https:\/\/doi.org\/10.1089\/gtmb.2020.0279.","journal-title":"Genetic Testing and Molecular Biomarkers"},{"issue":"6","key":"1573_CR32","doi-asserted-by":"publisher","first-page":"dmm032946","DOI":"10.1242\/dmm.032946","volume":"11","author":"I Gregorio","year":"2018","unstructured":"Gregorio, I., Braghetta, P., Bonaldo, P., & Cescon, M. (2018). Collagen VI in healthy and diseased nervous system. Disease Models & Mechanisms, 11(6), dmm032946. https:\/\/doi.org\/10.1242\/dmm.032946.","journal-title":"Disease Models & Mechanisms"},{"issue":"1","key":"1573_CR33","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.210304","volume":"12","author":"CG Chen","year":"2022","unstructured":"Chen, C. G., & Iozzo, R. V. (2022). Extracellular matrix guidance of autophagy: a mechanism regulating cancer growth. Open Biology, 12(1), 210304 https:\/\/doi.org\/10.1098\/rsob.210304.","journal-title":"Open Biology"},{"issue":"2","key":"1573_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3892\/ijo.2019.4825","volume":"55","author":"KG Owusu-Ansah","year":"2019","unstructured":"Owusu-Ansah, K. G., Song, G., Chen, R., Edoo, M. I. A., Li, J., Chen, B., Wu, J., Zhou, L., Xie, H., Jiang, D., & Zheng, S. (2019). COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer. International Journal of Oncology, 55(2), 391\u2013404. https:\/\/doi.org\/10.3892\/ijo.2019.4825.","journal-title":"International Journal of Oncology"},{"issue":"3","key":"1573_CR35","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.7150\/thno.51245","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Liu, Z., Yang, X., Lu, W., Chen, Y., Lin, Y., Wang, J., Lin, S., & Yun, J. P. (2021). H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts. Theranostics, 11(3), 1473\u20131492. https:\/\/doi.org\/10.7150\/thno.51245.","journal-title":"Theranostics"},{"issue":"4","key":"1573_CR36","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3892\/ol.2021.12954","volume":"22","author":"N Li","year":"2021","unstructured":"Li, N., Liu, M., Cao, X., Li, W., Li, Y., & Zhao, Z. (2021). Identification of differentially expressed genes using microarray analysis and COL6A1 induction of bone metastasis in non-small cell lung cancer. Oncology Letters, 22(4), 693. https:\/\/doi.org\/10.3892\/ol.2021.12954.","journal-title":"Oncology Letters"},{"issue":"2","key":"1573_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188354","volume":"1873","author":"K van Loon","year":"2020","unstructured":"van Loon, K., Yemelyanenko-Lyalenko, J., Margadant, C., Griffioen, A. W., & Huijbers, E. J. M. (2020). Role of fibrillin-2 in the control of TGF-\u03b2 activation in tumor angiogenesis and connective tissue disorders. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1873(2), 188354. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188354.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"issue":"2","key":"1573_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3233\/cbm-181940","volume":"24","author":"S Shi","year":"2019","unstructured":"Shi, S., & Tian, B. (2019). Identification of biomarkers associated with progression and prognosis in bladder cancer via co-expression analysis. Cancer Biomarkers, 24(2), 183\u2013193. https:\/\/doi.org\/10.3233\/cbm-181940.","journal-title":"Cancer Biomarkers"},{"key":"1573_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/bs.irn.2020.03.005","volume":"151","author":"V Shevchenko","year":"2020","unstructured":"Shevchenko, V., Arnotskaya, N., Pak, O., Sharma, A., Sharma, H. S., Khotimchenko, Y., Bryukhovetskiy, A., & Bryukhovetskiy, I. (2020). Molecular determinants of the interaction between glioblastoma CD133+ cancer stem cells and the extracellular matrix. International Review of Neurobiology, 151, 155\u2013169. https:\/\/doi.org\/10.1016\/bs.irn.2020.03.005.","journal-title":"International Review of Neurobiology"},{"issue":"8","key":"1573_CR40","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10585-004-8251-4","volume":"21","author":"H Yang","year":"2004","unstructured":"Yang, H., Rouse, J., Lukes, L., Lancaster, M., Veenstra, T., Zhou, M., Shi, Y., Park, Y. G., & Hunter, K. (2004). Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis. Clinical & Experimental Metastasis, 21(8), 719\u2013735. https:\/\/doi.org\/10.1007\/s10585-004-8251-4.","journal-title":"Clinical & Experimental Metastasis"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01573-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01573-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01573-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:28:08Z","timestamp":1747639688000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01573-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1573"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01573-6","relation":{},"ISSN":["1559-0283"],"issn-type":[{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]},"assertion":[{"value":"18 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance With Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}